Dipeptidyl peptidase-4 inhibitors and angioedema: a class effect?
Diabet Med
; 30(4): e149-50, 2013 Apr.
Article
in En
| MEDLINE
| ID: mdl-23323612
ABSTRACT
BACKGROUND:
Dipeptidyl peptidase-4 (DPP-4) inhibitors have been reported to be generally well tolerated. However, angioedema has been reported as one of the rare adverse events of these drugs. CASE REPORT We report a case in which angioedema induced by vildagliptin disappeared after changing to another DPP-4 inhibitor, alogliptin.DISCUSSION:
Our case suggests that there is a difference in the risk of angioedema among DPP-4 inhibitors. To clarify this possibility, further investigation on the risk of angioedema among DPP-4 inhibitors is warranted.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrrolidines
/
Adamantane
/
Dipeptidyl-Peptidase IV Inhibitors
/
Angioedema
/
Nitriles
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
Diabet Med
Year:
2013
Document type:
Article